A Network Pharmacology Approach-Based Decoding of Resveratrol's Anti-Fibrotic Mechanisms

Inhalation of crystalline silica (CS) frequently leads to chronic lung inflammation and pulmonary fibrosis (PF), a condition with limited effective treatments. Resveratrol (Res) has demonstrated potential in PF treatment; however, its underlying mechanisms remain incompletely elucidated.